Asarfi Hospital

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE0DN001027
  • NSEID:
  • BSEID: 543943
INR
197.00
-0.9 (-0.45%)
BSENSE

Dec 05

BSE+NSE Vol: 6000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Net Sales
120.57
84.40
Other Operating Income
0.00
0.00
Total Operating income
120.57
84.40
Raw Material Cost
19.40
16.21
Purchase of Finished goods
9.09
4.31
(Increase) / Decrease In Stocks
-0.63
-0.20
Employee Cost
18.63
14.13
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
50.52
33.90
Total Expenditure (Excl Depreciation)
97.01
68.35
Operating Profit (PBDIT) excl Other Income
23.56
16.05
Other Income
7.52
1.67
Operating Profit (PBDIT)
31.08
17.72
Interest
4.08
2.69
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
27.00
15.03
Depreciation
12.68
8.79
Profit Before Tax
14.31
6.24
Tax
3.73
2.08
Provisions and contingencies
0.00
0.00
Profit After Tax
10.58
4.16
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
10.58
4.16
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
10.58
4.16
Equity Capital
19.68
19.68
Face Value
10.0
10.0
Reserves
61.31
50.73
Earnings per share (EPS)
5.38
2.11
Diluted Earnings per share
5.37
2.31
Operating Profit Margin (Excl OI)
19.54%
19.02%
Gross Profit Margin
22.39%
17.81%
PAT Margin
8.77%
4.93%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 42.86% vs 19.38% in Mar 2024

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 160.81% vs -47.51% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 48.23% vs 16.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 51.67% vs 100.75% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Asarfi Hospital With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
120.57
99.07
21.50
21.70%
Other Operating Income
0.00
0.00
0.00
Total Operating income
120.57
99.07
21.50
21.70%
Raw Material Cost
19.40
0.00
19.40
Purchase of Finished goods
9.09
21.14
-12.05
-57.00%
(Increase) / Decrease In Stocks
-0.63
-0.22
-0.41
-186.36%
Employee Cost
18.63
14.33
4.30
30.01%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
50.52
27.10
23.42
86.42%
Total Expenditure (Excl Depreciation)
97.01
62.35
34.66
55.59%
Operating Profit (PBDIT) excl Other Income
23.56
36.72
-13.16
-35.84%
Other Income
7.52
2.72
4.80
176.47%
Operating Profit (PBDIT)
31.08
39.44
-8.36
-21.20%
Interest
4.08
3.15
0.93
29.52%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
27.00
36.29
-9.29
-25.60%
Depreciation
12.68
5.95
6.73
113.11%
Profit Before Tax
14.31
30.34
-16.03
-52.83%
Tax
3.73
3.21
0.52
16.20%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
10.58
27.13
-16.55
-61.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
10.58
27.13
-16.55
-61.00%
Share in Profit of Associates
0.00
-0.02
0.02
100.00%
Minority Interest
0.00
-12.98
12.98
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.58
14.13
-3.55
-25.12%
Equity Capital
19.68
15.40
4.28
27.79%
Face Value
10.00
10.00
0.00
Reserves
61.31
85.96
-24.65
-28.68%
Earnings per share (EPS)
5.38
9.18
-3.80
-41.39%
Diluted Earnings per share
5.37
9.83
-4.46
-45.37%
Operating Profit Margin (Excl OI)
19.54%
37.06%
0.00
-17.52%
Gross Profit Margin
22.39%
36.63%
0.00
-14.24%
PAT Margin
8.77%
27.38%
0.00
-18.61%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 120.57 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 42.86% vs 19.38% in Mar 2024

Annual - Standalone Net Profit
Standalone Net Profit 10.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 160.81% vs -47.51% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.85 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 48.23% vs 16.93% in Mar 2024

Annual - Interest
Interest 4.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 51.67% vs 100.75% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.78%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024